RESVO

Japanese

WE ARE RESVO.

For all those who live
with neurodevelopmental disorders.

RESVO strives to realize the society where all the people smile and live a healthy life.
We currently work through collaboration with university research teams and pharmaceutical companies and develop diagnostic agents and treatments in the neurodevelopmental area such as schizophrenias. Our research technologies have been increasingly important in the treatment outside of the schizophrenia patients.
Our mission is to develop and identify the treatment options and ultimately cure neurodevelopmental disorders through collaborations with medical institutions and pharmaceutical companies beyond the boundaries of neurodevelopmental orders.

RESVO's SOLUTION

SOLUTION

Research and development related to neurodevelopmental and stress-related disorders. We have discovered the effectiveness of the free light chains (FLC) as a diagnostic and stratified serologic biomarker for psychiatric and neurodevelopmental disorder patients and have obtained the patent both in Japan and the U.S. We are currently working not only on the research and development related to FLC, but also on the development of the products and services related to neurodevelopmental and stress-related disorders utilizing the discoveries in the research process.

NEWS

INFOMATION

2018/10/15
リバネス、RESVOと「ストレスと免疫応答」に関する共同研究を開始
2018/10/09
弊社CTOの大西と島根大学医学部精神科、宮岡准教授の共著論文が「NewYorkTimes」に紹介されました
2018/10/01
厚生労働省が主催するジャパン・ヘルスケアベンチャー・サミット2018 in 横浜に参加します
お知らせを一覧で見る
CONTACT

Contact

Please visit our contact page for potential research partnering and collaborating.

お問い合わせはこちらから